(Sharecast News) - OptiBiotix Health announced the start of a clinical study with Hull University Teaching Hospitals NHS Trust on Tuesday, to assess whether its 'WellBiome' prebiotic could improve cardiac surgery outcomes and deliver potential cost savings for the NHS.
The AIM-traded life sciences group said the double-blind, placebo-controlled study would...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE